Enrique Arevalo

Enrique Arevalo is a seasoned expert in the field of biochemistry, biophysics, and molecular biology, currently serving as the Co-Founder and Chief Scientific Officer at Spectrus LLC since November 2017, where meticulous attention to scientific inquiries supports biotech clients. Prior experience includes a role as Principal Scientist at Momenta from April 2007 to November 2017, leading predictive modeling teams for disease and treatment biomarker discovery. Enrique's earlier positions include Senior Research Scientist at Northeastern University specializing in biomarker discovery from breast cancer tissue, and postdoctoral research at both Massachusetts General Hospital and Harvard Medical School, where significant work on the serotonin (5HT3R) receptor was conducted. Educational qualifications include a PhD in Biochemistry, Biophysics, and Molecular Biology from The City University of New York and a Bachelor's degree in Chemistry from Pontificia Universidad Católica del Perú.